Montara Therapeutics, Inc.
Zachary Hill is a seasoned scientific professional with extensive experience in the biotechnology sector. Currently serving as VP of Discovery Chemistry at Montara Therapeutics, Inc., Hill has previously acted as Chief Scientific Officer and Co-Founder of Soteria Biotherapeutics, as well as holding various consultant positions. Hill's academic credentials include a Postdoctoral Fellowship in Chemical Biology and Protein Engineering from the University of California, San Francisco, and a Ph.D. in Organic Chemistry from the University of Washington.
This person is not in any teams
Montara Therapeutics, Inc.
1 followers
We are Montara Therapeutics, a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy. Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.